â??COMPARATIVE EVALUATION OF EFFICACY OF 2% LIGNOCAINE AND 3% MEPIVACAINE IN ACHIEVING PULPAL ANAESTHESIA IN CONTROLLED HYPERTENSIVE PATIENTS WITH SYMPTOMATIC IRREVERSIBLE PULPITIS ?- A RANDOMIZED CLINICAL TRIA

Shanmugapriya K0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•1. Able to provide informed consent.
•2. Carious mandibular molars with diagnosis of symptomatic irreversible Pulpitis.
•3. Patients who will be currently experiencing active pain in mandibular molars.
•4. Participants should not be under any medications that would alter pain perception.
•5. The patients should be clinically diagnosed with irreversible pulpitis, determined by spontaneous pain and prolonged response to cold testing with Endofrost (Coltene- Roeko) and a positive response to electric pulp testing, with absence of any periapical radiolucency on radiographs except for a mild widening of periodontal ligament space and a vital coronal pulp on access opening.
•6. Every patient should have at least one opposing or contralateral molar without any deep coronal restoration, extensive caries, periodontal disease, which will be used as a control while pulp testing.
•7. Blood pressure should be in the range of 120/80mm Hg to 160/100mm Hg.

•1. Allergies to local anaesthetics or sulphites.
•2. Below the age of 18 years.
•3. History of significant medical conditions.
•4. Taking any medication, which may affect the pain assessment.
•5. Active periapical pathosis.
•6. Pregnant and Lactating women.
•7. Mandibular molars without vital pulp tissue will be later excluded during endodontic procedures.

发起方

Shanmugapriya K